Ciliary Body and Choroid Melanoma, Medium/Large Size Completed Phase 2 Trials for Cediranib (DB04849)

IndicationStatusPhase
DBCOND0030825 (Ciliary Body and Choroid Melanoma, Medium/Large Size)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00243061AZD2171 in Treating Patients With Recurrent or Stage IV MelanomaTreatment